Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: Results of the GRAAPH-2003 study

Blood

Volumn 109, Issue 4, 2007, Pages 1408-1413

  De Labarthe, Adrienne ^a   Rousselot, Philippe ^b   Huguet Rigal, Françoise ^c   Delabesse, Eric ^d   Witz, Francis ^e   Maury, Sébastien ^f   Réa, Delphine ^a   Cayuela, Jean Michel ^a   Vekemans, Marie Christine ^g   Reman, Oumedaly ^h   Buzyn, Agnès ^d   Pigneux, Arnaud ⁱ   Escoffre, Martine ^j   Chalandon, Yves ^k   MacIntyre, Elizabeth ^d   Lhéritier, Véronique ^l   Vernant, Jean Paul ^m   Thomas, Xavier ^l   Ifrah, Norbert ⁿ   Dombret, Hervé ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c CHU PURPAN   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e CHU NANCY BRABOIS   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h CAEN UNIVERSITY HOSPITAL   (France)

ⁱ HAUT LÉVÊQUE HOSPITAL   (France)

^j RENNES UNIVERSITY HOSPITAL   (France)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁿ ANGERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMATINIB; METHOTREXATE; MITOXANTRONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; FEMALE; HUMAN; HYPERTENSION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LUNG ASPERGILLOSIS; MALE; MUCOSA INFLAMMATION; NAUSEA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PHILADELPHIA CHROMOSOME POSITIVE CELL; PLEURA EFFUSION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SIDE EFFECT; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 33846916856     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-03-011908     Document Type: Article

References (17)

1. Radich JP. Philadelphia chromosome-positive acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2001;15:21-36.
2. Hoelzer D, Gökbuget N. Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol. 2000;36:49-58.
3. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547-561.
4. Gleissner B, Gökbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood. 2002;99:1536-1543.
5. Dombret H, Gabert J, Boiron JM, et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood. 2002;100:2357-2366.
6. Thomas X, Boiron JM, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004;22:4075-4086.
7. Ottmann OG, Drucker BJ, Sawyers CL, et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood. 2002;100:1965-1971.
8. Yanada M, Takeuchi J, Sugiura I, et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol. 2006;24:460-466.
9. Lee KH, Lee JH, Choi SJ, et al. Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 2005;19:1509-1516.
10. Thomas DA, Faderl S, Cortes J, et al. Outcome with the hyper-CVAD and imatinib mesylate regimen in Philadelphia (Ph) positive acute lymphocytic leukemia [abstract]. Blood. 2005;106. Abstract 1830.
11. Ribera JM, Oriol A, Gonzalez M, et al. Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate [abstract]. Blood. 2004;104(suppl 1). Abstract 4483.
12. + ALL patients: results of the GIMEMA prospective study LAL0201 [abstract]. Blood. 2004;104(suppl 1). Abstract 2739.
13. +ALL). Blood. 2006;108:1469-1477.
14. Réa D, Legros L, Raffoux E, et al. High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphiapositive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia. Leukemia. 2006;20:400-403.
15. Dombret H, Witz F, de Botton S, et al. Imatinib combined with intensive HAM chemotherapy as consolidation of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1-ALL). Preliminary results of the AFR03 phase I/II study [abstract]. Blood. 2004;104. Abstract 2741.
16. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia. 2003;17:2318-2357.
17. + ALL) developing resistance to imatinib [abstract]. Blood. 2005;106 (suppl 1). Abstract 147.